Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale CEO sold 13,898 shares at $1.23 ($17,082)
  2. EFFECT Other Notice of Effectiveness
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. 8-K Event Executive or director change
  9. 4 Grant or award Chief Financial Officer acquired 17,500 shares (grant or award)
  10. SC 13G Stake Amended Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  19. SC 13G Stake Amended Statement of Ownership
  20. 8-K Event Other events

Page 8 of 41 · 801 filings